The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
DNA damage leads to the incorporation of defects and aberrations in the genome that often result in functional mutations. When these mutations occur in genes coding for vital proteins and/or enzymes, it leads to the development of genetic diseases. However, our biological system is equipped with a robust repair mechanism capable of correcting damaged DNA sequences. PARP inhibitors and other similar therapeutics are designed to augment the body’s innate DNA repair mechanism and aid in the treatment of diseases associated with genetic aberrations.
The global DNA Repair Drugs market size is expected to reach US$ 1993.3 million by 2029, growing at a CAGR of 18.4% from 2023 to 2029. The market is mainly driven by the significant applications of DNA Repair Drugs in various end use industries. The expanding demands from the Oncological and Stroke, are propelling DNA Repair Drugs market. PARP Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Other segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for DNA Repair Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global DNA Repair Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global DNA Repair Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, DNA Repair Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of DNA Repair Drugs covered in this report include 4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, British Columbia Cancer Agency, Cambridge University Hospitals NHS Foundation Trust, Genentech, Georgetown University, German Breast Group and GlaxoSmithKline, etc.
The global DNA Repair Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- 4SC AG
- ARCAGY/ GINECO GROUP
- Bristol Myers Squibb
- British Columbia Cancer Agency
- Cambridge University Hospitals NHS Foundation Trust
- Genentech
- Georgetown University
- German Breast Group
- GlaxoSmithKline
- Jiangsu Hengrui Medicine
- Johnson & Johnson
- Jonsson Comprehensive Cancer Center
- Karyopharm Therapeutics
- KuDOS Pharmaceuticals
- National Health Service
- National Institutes of Health
- Tesaro
Global DNA Repair Drugs market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global DNA Repair Drugs market, Segment by Type:
- PARP Inhibitors
- Other
Global DNA Repair Drugs market, by Application:
- Oncological
- Stroke
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of DNA Repair Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of DNA Repair Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 DNA Repair Drugs Market Overview
1.1 DNA Repair Drugs Product Overview
1.2 DNA Repair Drugs Market Segment by Type
1.2.1 PARP Inhibitors
1.2.2 Other
1.3 Global DNA Repair Drugs Market Size by Type
1.3.1 Global DNA Repair Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global DNA Repair Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global DNA Repair Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America DNA Repair Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe DNA Repair Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific DNA Repair Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America DNA Repair Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa DNA Repair Drugs Sales Breakdown by Type (2018-2023)
2 Global DNA Repair Drugs Market Competition by Company
2.1 Global Top Players by DNA Repair Drugs Sales (2018-2023)
2.2 Global Top Players by DNA Repair Drugs Revenue (2018-2023)
2.3 Global Top Players by DNA Repair Drugs Price (2018-2023)
2.4 Global Top Manufacturers DNA Repair Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 DNA Repair Drugs Market Competitive Situation and Trends
2.5.1 DNA Repair Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by DNA Repair Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Repair Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into DNA Repair Drugs Market
2.8 Key Manufacturers DNA Repair Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 DNA Repair Drugs Status and Outlook by Region
3.1 Global DNA Repair Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global DNA Repair Drugs Historic Market Size by Region
3.2.1 Global DNA Repair Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global DNA Repair Drugs Sales in Value by Region (2018-2023)
3.2.3 Global DNA Repair Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global DNA Repair Drugs Forecasted Market Size by Region
3.3.1 Global DNA Repair Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global DNA Repair Drugs Sales in Value by Region (2024-2029)
3.3.3 Global DNA Repair Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global DNA Repair Drugs by Application
4.1 DNA Repair Drugs Market Segment by Application
4.1.1 Oncological
4.1.2 Stroke
4.2 Global DNA Repair Drugs Market Size by Application
4.2.1 Global DNA Repair Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global DNA Repair Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global DNA Repair Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America DNA Repair Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe DNA Repair Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific DNA Repair Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America DNA Repair Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa DNA Repair Drugs Sales Breakdown by Application (2018-2023)
5 North America DNA Repair Drugs by Country
5.1 North America DNA Repair Drugs Historic Market Size by Country
5.1.1 North America DNA Repair Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America DNA Repair Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America DNA Repair Drugs Sales in Value by Country (2018-2023)
5.2 North America DNA Repair Drugs Forecasted Market Size by Country
5.2.1 North America DNA Repair Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America DNA Repair Drugs Sales in Value by Country (2024-2029)
6 Europe DNA Repair Drugs by Country
6.1 Europe DNA Repair Drugs Historic Market Size by Country
6.1.1 Europe DNA Repair Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe DNA Repair Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe DNA Repair Drugs Sales in Value by Country (2018-2023)
6.2 Europe DNA Repair Drugs Forecasted Market Size by Country
6.2.1 Europe DNA Repair Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe DNA Repair Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific DNA Repair Drugs by Region
7.1 Asia-Pacific DNA Repair Drugs Historic Market Size by Region
7.1.1 Asia-Pacific DNA Repair Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific DNA Repair Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific DNA Repair Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific DNA Repair Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific DNA Repair Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific DNA Repair Drugs Sales in Value by Region (2024-2029)
8 Latin America DNA Repair Drugs by Country
8.1 Latin America DNA Repair Drugs Historic Market Size by Country
8.1.1 Latin America DNA Repair Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America DNA Repair Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America DNA Repair Drugs Sales in Value by Country (2018-2023)
8.2 Latin America DNA Repair Drugs Forecasted Market Size by Country
8.2.1 Latin America DNA Repair Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America DNA Repair Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa DNA Repair Drugs by Country
9.1 Middle East and Africa DNA Repair Drugs Historic Market Size by Country
9.1.1 Middle East and Africa DNA Repair Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa DNA Repair Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa DNA Repair Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa DNA Repair Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa DNA Repair Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa DNA Repair Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 4SC AG
10.1.1 4SC AG Company Information
10.1.2 4SC AG Introduction and Business Overview
10.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 4SC AG DNA Repair Drugs Products Offered
10.1.5 4SC AG Recent Development
10.2 ARCAGY/ GINECO GROUP
10.2.1 ARCAGY/ GINECO GROUP Company Information
10.2.2 ARCAGY/ GINECO GROUP Introduction and Business Overview
10.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Products Offered
10.2.5 ARCAGY/ GINECO GROUP Recent Development
10.3 Bristol Myers Squibb
10.3.1 Bristol Myers Squibb Company Information
10.3.2 Bristol Myers Squibb Introduction and Business Overview
10.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bristol Myers Squibb DNA Repair Drugs Products Offered
10.3.5 Bristol Myers Squibb Recent Development
10.4 British Columbia Cancer Agency
10.4.1 British Columbia Cancer Agency Company Information
10.4.2 British Columbia Cancer Agency Introduction and Business Overview
10.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 British Columbia Cancer Agency DNA Repair Drugs Products Offered
10.4.5 British Columbia Cancer Agency Recent Development
10.5 Cambridge University Hospitals NHS Foundation Trust
10.5.1 Cambridge University Hospitals NHS Foundation Trust Company Information
10.5.2 Cambridge University Hospitals NHS Foundation Trust Introduction and Business Overview
10.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Products Offered
10.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Development
10.6 Genentech
10.6.1 Genentech Company Information
10.6.2 Genentech Introduction and Business Overview
10.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Genentech DNA Repair Drugs Products Offered
10.6.5 Genentech Recent Development
10.7 Georgetown University
10.7.1 Georgetown University Company Information
10.7.2 Georgetown University Introduction and Business Overview
10.7.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Georgetown University DNA Repair Drugs Products Offered
10.7.5 Georgetown University Recent Development
10.8 German Breast Group
10.8.1 German Breast Group Company Information
10.8.2 German Breast Group Introduction and Business Overview
10.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 German Breast Group DNA Repair Drugs Products Offered
10.8.5 German Breast Group Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GlaxoSmithKline DNA Repair Drugs Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Jiangsu Hengrui Medicine
10.10.1 Jiangsu Hengrui Medicine Company Information
10.10.2 Jiangsu Hengrui Medicine Introduction and Business Overview
10.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Products Offered
10.10.5 Jiangsu Hengrui Medicine Recent Development
10.11 Johnson & Johnson
10.11.1 Johnson & Johnson Company Information
10.11.2 Johnson & Johnson Introduction and Business Overview
10.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Johnson & Johnson DNA Repair Drugs Products Offered
10.11.5 Johnson & Johnson Recent Development
10.12 Jonsson Comprehensive Cancer Center
10.12.1 Jonsson Comprehensive Cancer Center Company Information
10.12.2 Jonsson Comprehensive Cancer Center Introduction and Business Overview
10.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Products Offered
10.12.5 Jonsson Comprehensive Cancer Center Recent Development
10.13 Karyopharm Therapeutics
10.13.1 Karyopharm Therapeutics Company Information
10.13.2 Karyopharm Therapeutics Introduction and Business Overview
10.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Karyopharm Therapeutics DNA Repair Drugs Products Offered
10.13.5 Karyopharm Therapeutics Recent Development
10.14 KuDOS Pharmaceuticals
10.14.1 KuDOS Pharmaceuticals Company Information
10.14.2 KuDOS Pharmaceuticals Introduction and Business Overview
10.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Products Offered
10.14.5 KuDOS Pharmaceuticals Recent Development
10.15 National Health Service
10.15.1 National Health Service Company Information
10.15.2 National Health Service Introduction and Business Overview
10.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 National Health Service DNA Repair Drugs Products Offered
10.15.5 National Health Service Recent Development
10.16 National Institutes of Health
10.16.1 National Institutes of Health Company Information
10.16.2 National Institutes of Health Introduction and Business Overview
10.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 National Institutes of Health DNA Repair Drugs Products Offered
10.16.5 National Institutes of Health Recent Development
10.17 Tesaro
10.17.1 Tesaro Company Information
10.17.2 Tesaro Introduction and Business Overview
10.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Tesaro DNA Repair Drugs Products Offered
10.17.5 Tesaro Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 DNA Repair Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 DNA Repair Drugs Industrial Chain Analysis
11.4 DNA Repair Drugs Market Dynamics
11.4.1 DNA Repair Drugs Industry Trends
11.4.2 DNA Repair Drugs Market Drivers
11.4.3 DNA Repair Drugs Market Challenges
11.4.4 DNA Repair Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 DNA Repair Drugs Distributors
12.3 DNA Repair Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
